Stock Price
211.90
Daily Change
0 0%
Monthly
-9.06%
Yearly
-1.53%
Q2 Forecast
200.76

Sartorius reported EUR1.26 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 1.3 1.22 Apr/23
FY2025Q4 Dec/2025 1.27 1.33 1.04 Feb/03
FY2025Q3 Sep/2025 0.63 1.08 0.21 Oct/16
FY2025Q2 Jun/2025 0.47 1.28 0.34 Jul/22
FY2025Q1 Mar/2025 1.22 0.98 1.01 Apr/16




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
Avita Medical AUD -0.38 0 Dec/2025
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
IQVIA Holdings USD 3.42 0.42 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Organon & Co USD 0.63 0.38 Dec/2025
Revvity USD 1.7 0.52 Dec/2025
Sartorius EUR 1.26 0.63 Dec/2025
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Viatris USD 0.57 0.1 Dec/2025
Xeris Pharmaceuticals USD 0.05 0.05 Dec/2025